<DOC>
	<DOCNO>NCT01888289</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics bioequivalence isotretinoin formulation administration single dos normal , non-smoking , healthy male fast condition</brief_summary>
	<brief_title>Bioequivalence Study Isotretinoin Capsules 40 mg Under Fasting Condition</brief_title>
	<detailed_description>An open label , randomize , two-treatment , single dose , oral bioequivalence study Isotretinoin capsule 40 mg Dr. Reddy 's Laboratories Limited , fast condition</detailed_description>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>1 . Healthy male 18 45 year age inclusive . 2 . Informed nature study give write informed consent . 3 . Have body weight within 15 % appropriate range define 1983 Metropolitan Life Company table weigh least 125 lb . ( Appendix I ) . Exclusion Criteria 1 . Hypersensitivity isotretinoin related compound . 2 . Any history clinical condition might affect drug absorption , metabolism excretion . 3 . Recent history mental illness , drug addiction , drug abuse alcoholism . 4 . Donation great 500 ml blood past 4 week prior study dose difficulty donate blood . 5 . Received investigational drug within 4 week prior study dose . 6 . Currently take prescription medication within 7 day prior study dose overthecounter medication within 3 day study dose . This prohibition include vitamin herbal preparation take nutritional supplement nontherapeutic indication judge attend physician . 7 . Regular tobacco use 3 month prior study dose .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2001</verification_date>
</DOC>